Trulieve Cannabis (TCNNF) Depreciation & Amortization - Total (2020 - 2023)
Trulieve Cannabis (TCNNF) recorded quarterly Depreciation & Amortization - Total of -$1.9 million in Q4 2023, down 110.17% quarter-over-quarter from $18.7 million in Q3 2023, and up 73.64% on a YoY basis from -$1.1 million in Q4 2022.
Trulieve Cannabis (TCNNF) Depreciation & Amortization - Total (2020 - 2023) Analysis & Trends
Trulieve Cannabis' Depreciation & Amortization - Total history runs 4 years deep, the most recent figure standing at -$1.9 million for Q4 2023.
- In Q4 2023, Depreciation & Amortization - Total rose 73.64% year-over-year to -$1.9 million; the TTM figure through Sep 2024 stood at -$1.9 million (down 105.95% YoY), while the FY2025 annual figure was $25.2 million, down 51.01% from the prior year.
- Depreciation & Amortization - Total was -$1.9 million for Q4 2023 at Trulieve Cannabis, down from $18.7 million in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of $20.5 million in Q1 2023 to a low of -$7.2 million in Q4 2022.
- Historically, Depreciation & Amortization - Total has averaged $8.4 million across 4 years, with a median of $7.3 million in 2021.
- Biggest YoY gain for Depreciation & Amortization - Total was 176.79% in 2022; the steepest drop was 570.35% in 2022.
- A 4-year view of Depreciation & Amortization - Total shows it stood at $10.4 million in 2020, then tumbled by 110.35% to -$1.1 million in 2021, then slumped by 570.35% to -$7.2 million in 2022, then surged by 73.64% to -$1.9 million in 2023.
- The last three Depreciation & Amortization - Total figures came in at -$1.9 million (Q4 2023), $18.7 million (Q3 2023), and $20.5 million (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1.90 Mn |
| Sep 30, 2023 | 18.68 Mn |
| Mar 31, 2023 | 20.50 Mn |
| Dec 31, 2022 | -7.21 Mn |
| Sep 30, 2022 | 18.82 Mn |
| Jun 30, 2022 | 20.10 Mn |
| Mar 31, 2022 | 15.50 Mn |
| Dec 31, 2021 | -1.08 Mn |
| Sep 30, 2021 | 8.10 Mn |
| Jun 30, 2021 | 7.30 Mn |
| Mar 31, 2021 | 5.60 Mn |
| Dec 31, 2020 | 10.40 Mn |
| Sep 30, 2020 | 3.90 Mn |
| Jun 30, 2020 | 3.60 Mn |
| Mar 31, 2020 | 3.20 Mn |